Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

James Young, MD

216.444.2333

James Young, MD
Department: Endocrinology and Metabolism Institute
Institute Chair
Location: Cleveland Clinic Main Campus
Mail Code NA21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2333
DeskDesk:216.444.2333
WorkFax:216.636.3206
James Young, MD
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code NA21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2270
DeskDesk:216.444.6697
WorkFax:216.636.3206
James Young, MD
Department: Critical Care Center
Location: Cleveland Clinic Main Campus
Mail Code NA21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
DeskDesk:216.444.6743
WorkFax:216.636.3206
James Young, MD
Department: Education Institute
Executive Dean
Location: Cleveland Clinic Main Campus
Mail Code NA21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2333
DeskDesk:216.444.2333
WorkFax:216.636.3206
James Young, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code NA21
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
DeskDesk:216.444.6743
WorkFax:216.636.3206
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr. Young is Professor of Medicine and Executive Dean, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Chairman of the Cleveland Clinic Endocrinology & Metabolism Institute. He is also Physician Director of Institutional Relations and Development, and a Medical Director of the Kaufman Center for Heart Failure. He holds the George and Linda Kaufman Chair and is the Study Chairman of the NIH, FDA, and CMS Interagency Registry for Mechanical Circulatory Assist Support (INTERMACS). He holds a joint appointment in the Cleveland Clinic Multi-organ Transplant Center. Dr. Young is certified as a Diplomat of the American Board of Internal Medicine as well as the subspecialty of Cardiovascular Disease and holds medical licensure from the states of California, Illinois, Ohio, Pennsylvania and Texas.

Dr. Young spent his early years in the San Francisco Bay area and then attended the University of Kansas, where he received his Bachelor of Arts degree with Honors in Biology and was a resident of Stephenson Scholarship Hall. He matriculated to Baylor College of Medicine in Houston, Texas, where he was awarded his Medical Doctor degree cum laude in 1974 and was elected to the Alpha Omega Alpha medical honor society. Dr. Young remained in Houston at Baylor Affiliated Hospitals where he completed his clinical training, subsequently joined the faculty and was named Professor of Medicine with tenure in 1992. During this time, he was the Clinical Coordinator and Scientific Director for Dr. Michael E. DeBakey’s Multi-organ Transplant Center at The Methodist Hospital and Baylor College of Medicine.

Dr. Young relocated to Cleveland and the Cleveland Clinic in 1995 where he was named Head of the Section of Heart Failure and Cardiac Transplant Medicine in the Department of Cardiovascular Disease. In 1998 Dr. Young and his surgical colleague Patrick McCarthy, MD, created the Kaufman Center for Heart Failure at Cleveland Clinic.

Dr. Young’s research activities began during his residency and fellowship training while he was a Lipid Research Clinic (LRC) physician. He subsequently focused his efforts on heart failure, mechanical circulatory support, and cardiac transplant therapeutics, including early experiences with dopamine receptor agonists, angiotensin-converting enzyme inhibitors, beta blockers, calcium channel blockers, angiotensin receptor blockers, many new immunosuppressants and a variety of parenteral inotropes and vasodilators. He has collaborated extensively with his basic science research associates, focusing on translational research related to the molecular biology of cardiac remodeling, allograft arteriopathy and transplanted heart rejection.

Dr. Young has participated in more than 150 clinical trials as an investigator and served as the U.S. Principal or Co-Principal Investigator for the HOPE, RESOLVED, SPICE, VMAC, MIRACLE-ICD, RED-HF, ACCLAIM, ONTARGET, TRENSCEND and CHARM multi-center clinical trials. He has published more than 550 manuscripts and several textbooks. Professionally, Dr. Young gains the greatest satisfaction from his contributions to the development and administration of donor organ procurement programs, his efforts to secure recognition for the emerging cardiology subspecialty of ‘heart failure and cardiac transplant medicine, and his collaborations with basic and clinical scientists.

Professional Highlights

  • International Society of Heart and Lung Transplantation, Board Member and Past President
  • Heart Failure Society of America, Board Member
  • American Society of Transplantation, Board Member

Education & Fellowships

Fellowship - Baylor College of Medicine Affiliated Hospitals
Cardiology
Houston, TX USA
1979
Residency - Baylor College of Medicine Affiliated Hospitals
Internal Medicine
Houston, TX USA
1977
Internship - Baylor College of Medicine Affiliated Hospitals
Internal Medicine
Houston, TX USA
1975
Medical School - Baylor College of Medicine
Houston, TX USA
1974
Undergraduate - University of Kansas
Biology
Lawrence, KS USA
1971

Certifications

  • Internal Medicine- Cardiovascular Disease
  • Internal Medicine

Specialty Interests

Cardiomyopathy, cardiac tumors, heart failure, heart transplantation, ventricular assist device

Awards & Honors

  • Fellow, American College of Cardiology
  • Fellow, American College of Chest Physicians
  • Fellow, American College of Physicians
  • Fellow, American Heart Association
  • Fellow, European Society of Cardiology
  • Gold Medal for Meritorious Service to Yugoslavian Cardiology Society
  • Naifeh and Smita Guide: The Best Doctors in America
  • Castle Connolly Guide: American Top Doctors

Memberships

  • American College of Cardiology
  • American Heart Association
  • European Society of Cardiology
  • Heart Failure Society of America
  • International Society for Heart and Lung Transplantation

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/30/2014, Dr. Young has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Fiduciary Role. Dr. Young serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

  • Cleveland Heart, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English